01—Abstract
Summary
Summary of the 8-K filed February 26, 2026. Cited figures are marked; the original filing is the authoritative source.
DexCom, Inc. (DXCM) filed an 8-K on February 26, 2026 announcing the appointment of Albert F.
"Rick" Osterloh, IV to its Board of Directors, effective immediately. The Board increased its size from eleven to twelve directors under the Amended and Restated Bylaws, and Mr. Osterloh will serve until the 2026 annual meeting of stockholders. He was also named to the Compensation Committee and the Technology Committee.
The Board determined he is independent under SEC and Nasdaq standards. Mr. Osterloh is currently Senior Vice President, Platforms & Devices at Google, overseeing Android, Chrome, Google Play, Pixel, Nest, and Fitbit. He previously served as President of Motorola Mobility and held senior product roles at Skype and Motorola.
The company says he brings expertise in innovation oversight, strategic transactions, and long-term strategic planning, and CEO Jake Leach cited his experience in scalable products that integrate emerging technologies. The filing discloses no related-party transactions and no arrangement under which he was selected.
Compensation is standard for a new non-employee director: an initial RSU grant with a fair value of $500,000a vesting annually over three years, plus a pro-rated annual RSU grant of about $101,027 tied to the 2026 annual meeting. The 8-K is a governance and board-composition event with no financial results, guidance, or operational changes disclosed.
02—Key points
Key Highlights
- Board expanded to twelve directors with the appointment of Rick Osterloh, effective February 26, 2026.
- Osterloh brings technology product leadership from Google (SVP, Platforms & Devices), including Android, Pixel, Nest, and Fitbit.
- Appointed to the Compensation Committee and Technology Committee, signaling a potential role in executive pay and technology strategy oversight.
- Board determined Osterloh is independent under SEC and Nasdaq listing standards.
- Initial equity grant of RSUs valued at $500,000, vesting annually over three years, plus a pro-rated 2026 annual grant of about $101,027.
- No related-party transactions or undisclosed arrangements with any person regarding his selection, per the filing.
- No financial results, guidance, or operational changes were disclosed; the filing is purely a governance event.
03—Questions
Frequently Asked Questions
Who is the new DexCom board member and what is his background?
Albert F. "Rick" Osterloh, IV is Senior Vice President, Platforms & Devices at Google, where he leads Android, Google Play, Chrome, and the Pixel, Nest, and Fitbit device portfolio. He previously served as President of Motorola Mobility (2014-2016), held senior product roles at Motorola Mobility and Skype, and earned degrees from Stanford, including an MBA.
Why does this appointment matter to investors?
It adds a director with major consumer hardware, platform, and AI-integrated product experience at a time when DexCom is focused on long-term product development. The appointment does not change financial guidance or operations, but it may signal the Board's emphasis on technology-driven product strategy and innovation oversight.
Is Osterloh independent, and does he have any conflicts of interest?
The Board determined he is independent under SEC and Nasdaq standards. The filing states he is not party to any transaction requiring disclosure under Item 404(a) of Regulation S-K and that no arrangement exists with any person regarding his selection as a director.
How is Osterloh compensated as a director?
He received an initial RSU grant with a fair value of $500,000 vesting annually over three years, subject to continued service. He is also eligible for a pro-rated annual RSU grant of about $101,027 around the 2026 annual meeting, which vests at the earlier of the next annual meeting or one year from grant. Equity awards accelerate in full upon a change in control.
When does Osterloh's term end, and will he need to stand for election?
His term expires at the 2026 annual meeting of stockholders. Because the filing describes the term as ending at that meeting, he would be expected to stand for election there, as is typical for directors appointed between annual meetings, though the filing itself does not explicitly state he will be nominated.
04—Continue